F. Xavier Bosch - Concepedia

Author

F. Xavier Bosch

Also Known As

Bosch, F. X., Bosch, F. Xavier, Bosch, F.X., F Bosch, F Bösch, F J Bosch José, F X BOSCH, F X Bosch, F XAVIER BOSCH, F Xavier Bosch

540

Publications

72.5K

Citations

111

H-Index

185

Concepts

All Affiliations

Institut Català d'Oncologia Centre international de recherche sur le cancer Institut d'Investigació Biomédica de Bellvitge Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública Johns Hopkins University

About

F. Xavier Bosch is an author at Institut Català d'Oncologia specializing in medicine, public health, and cervical cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	60	118	20.3K
2	Public Health	49	89	14.9K
3	Health Sciences	5	5	520
4	Education	1	1	10
5	Natural Sciences	1	1	253

F. Xavier Bosch

233

Publications

54K

Citations

H-Index

Page 1

	Year	Citations
Human papillomavirus is a necessary cause of invasive cervical cancer worldwide Jan M.M. Walboomers, Marcel V. Jacobs, M. Michele Manos, The Journal of Pathology	1999	9K
Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical Cancer Núbia Muñóz, F. Xavier Bosch, Sílvia de Sanjosé, New England Journal of Medicine	2003	6.2K
Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide Perspective F. Xavier Bosch, M. Michele Manos, Núbia Muñóz, JNCI Journal of the National Cancer Institute	1995	3.4K
Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study Silvia de Sanjosé, Wim Quint, Laia Alemany, The Lancet Oncology Invasive Cervical CancerEpidemiologyCervical Cancer ScreeningPrecancerous LesionsCervical Cancer	2010	2.7K
Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial Jorma Paavonen, David Jenkins, F. Xavier Bosch, The Lancet VaccinationVaccine SafetyInterim AnalysisPreventive MedicinePhase Iii Double-blind	2007	1.3K
Against which human papillomavirus types shall we vaccinate and screen? the international perspective Núbia Muñóz, F. Xavier Bosch, Xavier Castellsagué, International Journal of Cancer	2004	1.1K
Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysis Laia Bruni, Mireia Díaz, Leslie Barrionuevo-Rosas, The Lancet Global Health	2016	803
Male Circumcision, Penile Human Papillomavirus Infection, and Cervical Cancer in Female Partners Xavier Castellsagué, F. Xavier Bosch, Núbia Muñóz, New England Journal of Medicine	2002	800
IARC Monographs on the evaluation of carcinogenic risks to humans: Some traditional herbal medicines, some mycotoxins, naphthalene and styrene Ahti Anttila, Ramesh V. Bhat, James A. Bond, Chemoprevention StrategyPathologyToxicology TestingCarcinogenic RisksMycotoxins	2002	773
HPV Involvement in Head and Neck Cancers: Comprehensive Assessment of Biomarkers in 3680 Patients Xavier Castellsagué, Laia Alemany, Miquel Quer, JNCI Journal of the National Cancer Institute	2016	732

Page 1